Our results are in agreement with previous reports of intratumoral HGF expression in most lung tumour subtypes, with a strong HGF immunostaining reported in 42 to 70% of NSCLC tumours [59, 60, 61]. The gene discussed is HGF; the disease is non-small cell lung carcinoma.